Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Consumer Defensive Farm Products
Global Hemp Group Inc. is a Canada-based company. The Company is focused on two business segments: Industrial Hemp and Health & Wellness (Biopharma). The Industrial Hemp segment primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. It is also focused on aligning with its hemp agro-industrial zone (HAIZ) strategy to achieve a carbon-negative footprint. Its principal feature of the HAIZ concept is the proximity of the industrial plant to the supply of raw materials and final markets. The Health and Wellness segment is focused on the acquisition of exclusive licensing of patents and intellectual property (IP). It acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms.


CSE:GHG - Post by User

Global Hemp Group Inc
Bullboard Posts
User Avatar Image
(18)
•••
Comment by AccountabilityMon May 16, 2019 7:10pm
56 Views
Post# 29753537

RE:News Requested

RE:News RequestedLast year, the majority of the crops were in the field per the following news release dated May 30, 2018: 
https://www.globalhempgroup.com/05302018global-hemp-group-and-marijuana-company-of-america-provide-update-on-new-brunswick

40,000+ clones were planted in January, 2019 per the following news release:
https://www.globalhempgroup.com/01082019clone-production-at-global-hemp-groups-scio-oregon-hemp-project-underway-hemp-growers-license-renewed-for-2019

With the additional expense of cloning, we should have a early planting notice in the next week (assuming the 2018 history repeats itself in 2019).  Hopefully, it will be accompanied with an increase to the 109 and 125 acre plots, increased interest from offsetting farmers, and some indication of what they sold their biomass for. 

Good luck to all.  


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities